Dare Bioscience, Inc. Variable Lease, Payment
Dare Bioscience, Inc. (DARE) reported Variable Lease, Payment of $29.36 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:VariableLeasePayment · last filed 2026-08-13
- Dare Bioscience, Inc. variable lease, payment for the quarter ending 2026-06-30 was $29.36K, a 52.49% decline year-over-year.
- Dare Bioscience, Inc. variable lease, payment for the quarter ending 2026-03-31 was $34.31K, a 4.99% decline year-over-year.
- Dare Bioscience, Inc. variable lease, payment for the quarter ending 2025-06-30 was $61.81K.
- Dare Bioscience, Inc. variable lease, payment for the quarter ending 2025-03-31 was $36.12K.
- Dare Bioscience, Inc. variable lease, payment for fiscal 2025 was $124.20K, a 27.93% decline from fiscal 2024.
- Dare Bioscience, Inc. variable lease, payment for fiscal 2024 was $172.34K.
| Period end | Variable Lease, Payment 3 month | Variable Lease, Payment 6 month | Variable Lease, Payment 12 month |
|---|---|---|---|
| 2026-06-30 | $29.36K 10-Q · filed 2026-08-13 | $63.68K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $34.31K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $124.20K 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $61.81K 10-Q · filed 2026-08-13 | $97.92K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $36.12K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $172.34K 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |